Published in Cancer on February 25, 2013
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial. JAMA Intern Med (2015) 1.92
Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center. Cancer Epidemiol Biomarkers Prev (2015) 1.52
Is 20% of a loaf enough? Cancer (2013) 1.38
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest (2015) 1.16
Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer (2014) 1.12
Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res (2015) 1.11
Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10
Is 20% of a loaf enough? Cancer (2013) 1.09
Should CMS cover lung cancer screening for the fully informed patient? JAMA (2014) 1.09
Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs. J Hematol Oncol (2013) 1.07
Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS One (2015) 1.04
Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis. Am Health Drug Benefits (2014) 1.00
Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. PLoS One (2014) 0.90
Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer (2016) 0.89
Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening. J Med Screen (2014) 0.82
Low-Dose Radiation Induces Cell Proliferation in Human Embryonic Lung Fibroblasts but not in Lung Cancer Cells: Importance of ERK1/2 and AKT Signaling Pathways. Dose Response (2016) 0.81
High-risk older smokers' perceptions, attitudes, and beliefs about lung cancer screening. Cancer Med (2016) 0.81
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. J Thorac Oncol (2014) 0.81
We can do better than last place: improving the health of us women. Glob Adv Health Med (2013) 0.80
Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist (2013) 0.80
2016 reflections on the favorable cost-benefit of lung cancer screening. Ann Transl Med (2016) 0.78
'I still don't know diddly': a longitudinal qualitative study of patients' knowledge and distress while undergoing evaluation of incidental pulmonary nodules. NPJ Prim Care Respir Med (2015) 0.78
Status and perspectives of detection by low-dose computed tomography or computed radiography in surgical patients with lung cancer, based on a five-year study. Thorac Cancer (2015) 0.77
Early detection of lung cancer. F1000Res (2016) 0.77
Electromagnetic navigation transthoracic needle aspiration for the diagnosis of pulmonary nodules: a safety and feasibility pilot study. J Thorac Dis (2016) 0.76
Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics? PLoS One (2015) 0.76
Lung cancer in Brazil: epidemiology and treatment challenges. Lung Cancer (Auckl) (2016) 0.75
Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines. BMJ Open Respir Res (2016) 0.75
Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer. Exp Biol Med (Maywood) (2016) 0.75
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. Lung Cancer (2015) 0.75
Reply to lung cancer deaths averted by screening should be considered in the context of tobacco control policies. Cancer (2013) 0.75
Lung cancer screening with low-dose computed tomography. Radiol Clin North Am (2014) 0.75
Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. Cancer (2015) 0.75
Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs. Transl Lung Cancer Res (2015) 0.75
A novel technique for tumor localization and targeted lymphatic mapping in early-stage lung cancer. J Thorac Cardiovasc Surg (2017) 0.75
Interobserver variability in tumor contouring affects the use of radiomics to predict mutational status. J Med Imaging (Bellingham) (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol (2008) 4.49
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol (2003) 3.51
Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int (2008) 3.45
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Cancer statistics for African Americans. CA Cancer J Clin (2002) 2.45
The structural basis of blebbistatin inhibition and specificity for myosin II. Nat Struct Mol Biol (2005) 2.45
Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 2.44
Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer (2007) 2.43
International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2011) 2.40
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction (2007) 2.38
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
The impact of prevention on reducing the burden of cardiovascular disease. Circulation (2008) 2.05
Novel algorithms and the benefits of comparative validation. Bioinformatics (2013) 1.97
Tobacco control in the United States--recent progress and opportunities. CA Cancer J Clin (2009) 1.97
The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med (2012) 1.92
New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA (2011) 1.88
Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst (2013) 1.85
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol (2010) 1.83
Prospective evaluation of the sensitivity of physical examination in chest trauma. J Trauma (2002) 1.80
How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control (2006) 1.80
Electrical coupling between mammalian cones. Curr Biol (2002) 1.72
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol (2010) 1.58
Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord (2008) 1.55
Combining biomarkers to detect disease with application to prostate cancer. Biostatistics (2003) 1.54
State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev (2011) 1.54
Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev (2003) 1.53
Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin (2004) 1.52
Pesticide contamination inside farm and nonfarm homes. J Occup Environ Hyg (2005) 1.52
Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol (2013) 1.52
Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol (2009) 1.49
A system-wide intervention to improve HIV testing in the Veterans Health Administration. J Gen Intern Med (2008) 1.46
Automating arm movement training following severe stroke: functional exercises with quantitative feedback in a gravity-reduced environment. IEEE Trans Neural Syst Rehabil Eng (2006) 1.44
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc (2008) 1.42
A new method of predicting US and state-level cancer mortality counts for the current calendar year. CA Cancer J Clin (2004) 1.42
Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility. Cancer (2014) 1.41
Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report. J Med Case Rep (2008) 1.41
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin (2007) 1.33
Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control (2009) 1.33
The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer (2007) 1.30
Adhesion/cementation to zirconia and other non-silicate ceramics: where are we now? Dent Mater (2010) 1.26
Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control (2005) 1.25